FDA grants full approval to Pfizer Covid treatment Paxlovid for high-risk adults

May 25, 2023
Pfizer and the FDA view Paxlovid as an important complementary tool to vaccination that can help high-risk Americans manage their Covid infections.

from Health and Science https://ift.tt/Yusb2IQ
https://ift.tt/sENgyDk
https://ift.tt/z8knewI

Leave a Comment

No comments

Subscribe to: Post Comments ( Atom )
Powered by Blogger.